Cosmetic Plastic Surgeon serving North Atlanta

Cosmetic surgeon, Kamran Abolmaali, M.D. is a highly skilled, board-certified plastic surgeon who completed over 12 years of surgical training in top programs in New York and London. He attended esteemed Long Island Plastic Surgery Group residency program in Long Island, NY and Manhattan, after completing General Surgery residency at Marshall University. He is currently Board Certified in General Surgery with American Board of Surgery. He is also certified by the prestigious Royal College of Surgeons of England.

During his training, Dr. Kamran had the opportunity to operate with and train directly under supervision of the experts in the field of cosmetic and reconstructive surgery in New York. He specializes in aesthetic procedures of the face and body such as rhinoplasty, facelift, eyebrow lift, breast augmentation, tummy tuck and liposuction. In addition, he specializes in skin removal after weight loss surgery, and skin cancer plastic surgery. He also trained in hand surgery both in England and New York under the direction of the leaders in the field.

During his training in Long Island, he developed a personal interest in surgical management of migraine headache. Together with the neurologists, he has helped numerous patients to overcome their disabling condition by BOTOX injections or surgical intervention.

Extensive Cosmetic Plastic Surgeon Training

Dr. Kamran spent two years in a top surgical lab at Brigham and Women’s Hospital, Harvard Medical School, where he focused on new surgical techniques and combining molecular and clinical research to advance the field of surgery. He has multiple podium presentations in national and international meetings to present new innovative techniques in surgery. He authored multiple research papers in very highly rated journals such as the Journal of Surgery as well as contributing to multiple book chapters during his career.

Dr. Kamran is very well respected in the field among his peers and by his patients. He was the recipient of multiple distinction awards during medical school and residency programs. He won the Excellence in Patient Care prize from Cabell Huntington Hospital in 2013. He is actively involved in training of medical students and residents.

cosmetic plastic surgeon atlanta

KAMRAN ABOLMAALI, M.D.
Cosmetic Plastic Surgeon

Dr. Kamran Abolmaali is a highly skilled cosmetic plastic surgeon who completed over 12 years of surgical training in top programs in New York and London. He attended esteemed Long Island Plastic Surgery Group residency program in Long Island, NY and Manhattan, after completing General Surgery residency at Marshall University.  He is currently Board Certified in General Surgery with American Board of Surgery. He is also certified by the prestigious Royal College of Surgeons of England.

PUBLISHED ARTICLES IN LEADING PEER-REVIEWED JOURNALS

  1. Kamran Abolmaali, Catherine J. Sinnott, Michael  P. Catanzaro, Malack Hamade, Tommaso Addona, Thomas A. Davenport, Matthew S. Kilgo; Delayed-Immediate vs Immediate Microvascular Breast Reconstruction: A Comparison of Outcomes: Plastic and Reconstructive surgery 2018; submitted
  2. Sanford Z, Abolmaali K, Robinson D, Denning D; Blunt Trauma: an uncommon cause of traumatic common bile duct injury. Trauma case reports 2015
  3. Abolmaali K, B. A., Stearns AT, Rounds J, Rhoads DB, Ashley SW, Tavakkolizadeh A Circadian variation in intestinal dihydropyrimidine dehydrogenase (DPD) expression: A potential mechanism for benefits of 5FU chrono-chemotherapy. Surgery 2009; 146(2):269-73 [PMID: 19628084]
  4. Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, Atarod L,Ghazi BM, Isaeian A, Mahmoudi M, Abolmaali K, Mansouri D, Arshi S, Tarash NJ, Sherkat R,Akbari H, Amin R, Alborzi A, Kashef S, Farid R, Mohammadzadeh I, Shabestari MS, Nabavi M,Farhoudi A.Frequency and Clinical Manifestations of Patients with Primary Immunodeficiency Disorders in Iran: Update from the Iranian Primary Immunodeficiency Registry. Journal of Clinical Immunology 2006; 26(6):519-32 [PMID: 17024564]
  5. Rezaei N, Pourpak Z, Aghamohammadi A, Farhoudi A, Movahedi M, Gharagozlou M, Mirsaeid Ghazi B, Atarod L, Abolmaali K, Mahmoudi M, Mansouri D, Arshi S, Tarash NJ, Sherkat R, Amin R, Kashef S, Hosseini RF, Mohammadzadeh I, Shabestari MS, Nabavi M, Moin M. Consanguinity in Primary Immunodeficiency Disorders; the Report from Iranian Primary Immunodeficiency Registry. American Journal of Reproductive Immunology 2006; 56: 145–151 [PMID: 16836617]
  6. Huseini HF, Alavian SM, Heshmat R, Heydari MR, Abolmaali K. The efficacy of Liv-52 on liver cirrhotic patients: A randomised double-blind, placebo controlled first approach. Phytomedicine2005; 12: 619-24 [PMID: 16194047]
  7. Ghanei M, Abolmaali K, Aslani J. Efficacy of concomitant administration of Clarithromycin and Acetylcysteine in bronchiolitis obliterans in seventeen sulphur Mustard – exposed patients: an open label study. Current Therapeutic Research 2004; 65(6): 495-504
  8. Moin M, Aghamohammadi A, Farhoudi A, Pourpak Z, Rezaei N, Movahedi M, Gharagozlou M,Ghazi BM, Zahed A, Abolmaali K, Mahmoudi M, Emami L, Bashashati M. X-Linked Agammaglobulinemia: A Survey of 33 Iranian Patients. Immunological Investigations 2004; 33(1):81–93 [PMID: 15015835]
  9. Abolmaali K, Aghamohammadi A, Rezaei N. Human Leukocyte class I and II antigens in Iranian patients with common variable immunodeficiency; Acta Medica Iranica 2004; 42(4): 272-6.
  1. Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Rezaei N, Nikzad M, Movahedi M,Gharagozlou M, Atarod L, Ahmadi Afshar A, Bazargan N, Abolmaali K, Mahmoudi M. Adverse Effects of Intravenous Immunoglobulin Therapy in Patients with Antibody Deficiency; Iran J Allergy Asthma Immunol. 2003 Sep;2(3):121-126
  2. Movahedi M, Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Gharagozlou M, Mansouri D,Babaei Jandaghi A, Shahnavaz N, Rezaei N, Abolmaali K, Alizadeh Arasi Sh, Bakhshaei J, Vaziri M. Respiratory Manifestations of Chronic Granulomatous Disease; a clinical survey of patients from Iranian Primary Immunodeficiency Registry; Iranian Journal of Allergy Asthma and Immunology Mar 2003;1:45-51 [PMID: 17301356
  3. Aghamohammadi A, Moin M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, Movahedi M, Gharagozlou M, Mir Saeid Ghazi B, Atarod L, Hojati Ashrafi T, Mahmoudi M, Isaeian A, Mansouri D, Arshi S, Javaher Trash N, Akbari H, Sherkat R, Farid Hosseini MR, Hashemzadeh A, Mohammadzadeh I. The spectrum of primary immunodeficiency in Iran. Acta Med Iran 2002; 40(3): 165-170
  4. Aghamohammadi A, Moein M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, Movahedi M,Gharagozlou M, Ghazi BM, Mahmoudi M, Mansouri D, Arshi S, Trash NJ, Akbari H, Sherkat R,Hosayni RF, Hashemzadeh A, Mohammadzadeh I, Amin R, Kashef S, Alborzi A, Karimi A, Khazaei H. Primary immunodeficiency in Iran: first report of the national registry of PID in children & adults; Journal of Clinical Immunology 2002; 22(6): 375-80 [PMID: 12462337]
  5. Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Rezaei N, Abolmaali K, Movahedi M, Gharagozlou M, Ghazi BMS, Mahmoudi M. A 20-year survey of infectious complications in 64 patients with common variable immunodeficiency. Med J IR Iran 2002; 16(3): 123-128
  6. Aghamohammadi A, Moin M, Farhoudi A, Pourpak Z, Movahedi M, Abolmaali K, Rezaei N, Gharagozlou M, Amiri Kordestani L, Habibi Z, Mahmoudi M. The clinical spectrum of respiratory diseases in patients with primary antibody deficiencies. Iran J Allergy Asthma Immunol 2000; 1(3): 135-140
  7. Movahedi M, Aghamohammadi A, Rezaei N, Farhoudi A, Pourpak Z, Moin M, Gharagozlou M,Mansouri D, Arshi S, Atarod L, Mirsaeid Ghazi B, Shahnavaz N, Babaei Jandaghi A, Abolmaali K,Mahmoudi M, Bazargan N, Ahmadi Afshar A, Nabavi M. Gastrointestinal manifestations of patients with chronic granulomatous disease; Iranian Journal of Allergy, Asthma and immunology 2004; 3(2): 83-7 [PMID: 17301397]

PUBLISHED EXTRACTS

  • Delayed-Immediate vs. Immediate Free Autologous Breast Reconstruction A Comparison of Outcomes; Abolmaali, Kamran, MD; Catanzaro, Michael, DO, MS; Hamade, Malack, BS; Addona, Tommaso, MD, FACS; Davenport, Thomas, MD; Kilgo, Matthew S., MD, FACS; Plastic and Reconstructive Surgery 2017; 5(9S): 28
  • Corticosteroids phase-shift intestinal clocks and diurnal functional rhythms; Adam T Stearns, Anita Balakrishnan, Kamran Abolmaali, David B Rhoads, Stanley W Ashley, Ali Tavakkolizadeh; Gastroenterology 2009; 136(5): A-96
  • Contribution of proximal jejunum to intestinal glucose sensing and regulation of glucose absorption; Kamran Abolmaali, Adam T. Stearns, Anita Balakrishnan, David B. Rhoads, Stanley W. Ashley, Ali Tavakkolizadeh; Journal of American College of Surgeons 2009; 209(3): S11-S12
  • Does the size of Lap-Band impact long-term outcomes? Ali Ardestani, Kamran Abolmaali, David B. Lautz, Ali Tavakkolizadeh, MD; Surgery for Obesity and Related Diseases 2010; 6(3): S31
  • Therapeutic coating of proximal intestine blunts intestinal sweetness sensing mechanism and reduces SGLT1 expression: A novel therapeutic approach for diabetes and obesity; Kamran Abolmaali, Chenjie Xu, Jeffrey Karp, Ali A Tavakkoli; Journal of American College of Surgeons Sep 2010; 211(3): S21-22

LECTURES & PRESENTATIONS IN NATIONAL/INTERNATIONAL MEETINGS

American Society of Plastic Surgeons
2017 | Orlando, FL | Oral presentation
Delayed-Immediate vs. Immediate free autologous breast reconstruction: A comparison of outcomes

Southeastern Surgical Society
2013 | Jacksonville, FL | Poster presentation
Primary retroperitoneal mucinous cystadenocarcinoma; A rare case report

International Federation for Surgery for Obesity
2010 | Long Beach, CA – Plenary Oral
Potential role of bilio-pancreatic limb on intestinal sweetness sensing following gastric bypass surgery

American College of Surgeons Annual Clinical Congress (96th) – Surgical Forum
2010 | Washington DC – Oral presentation
Coating of proximal intestine blunts intestinal sweetness sensing mechanism and reduces SGLT1 expression; A Novel Therapeutic Approach for Obesity and Diabetes

American College of Surgeons Annual Clinical Congress (95th) – Surgical Forum
2009 | Chicago, IL – Oral presentation
Contribution of proximal jejunum to intestinal glucose sensing and regulation of glucose absorption

Society of University Surgeons Annual meeting (4th)
2009 | Fort Lauderdale, FL
Diurnal variation in Dihydropyrimidine Dehydrogenase expression and its role in cancer chronotherapy (Oral)

Congress of  the European Academy of Allergology and Clinical Immunology (21st)
2002 | Naples, Italy

  • The frequency of consanguinity in primary immunodeficient patients, registered in Iranian Primary Immunodeficiency Registry (Poster)
  • Survey of infectious complications in 64 patients with common variable immunodeficiency (poster)
  • Primary immunodeficiency diseases in Iran; the report of the national registry in children and adults (Poster)
  • X-linked agammaglobulinemia in Iran; Clinical and immunologic  analysis of 29 patients
  • Clinical manifestations of chronic granulomatous disease, A clinical survey of patients of the Iranian primary immunodeficiency registry (Poster)

European Congress of Clinical Microbiology and Infectious Diseases (12th)
2002 | Milan, Italy

  • The clinical spectrum of infections in patients with primary phagocytic disorders; a clinical survey of patients from Iranian primary immunodeficiency registry (Poster)
  • The clinical spectrum of infections in patients with primary hypogamaglobulinemia; a clinical    survey of patients from Iranian primary immunodeficiency registry (Poster)

Meeting of European Society for Immunodeficiencies (10th)
2002 | Weimar, Germany
Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with X-linked agammaglobulinemia; (contributor)

International Congress of Immunology (11th)
2001 | Stockholm, Sweden
Primary immunodeficiency in Iran; First report of Iranian primary immunodeficiency registry (contributor)

European Respiratory Congress (11th)
2001 | Berlin, Germany

  • The clinical spectrum of respiratory diseases in patients with primary humoral immunodeficiency disorders; a survey of patients from Iranian primary immunodeficiency registry (oral)
  • Lung manifestations of chronic granulomatous disease; a survey of patients from Iranian primary immunodeficiency registry (Oral)